insights_auto
8NE の上昇理由: 3.28%?
さらに詳しくchevron_right
8NE:FRA
Lisata Therapeutics, Inc.
€0.94
arrow_upward
+3.28%(+0.030) 1 日
10月9日, 8:05:36 GMT+2 · EUR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_auto8NE の上位の分析情報を生成しています...
始値
€0.94
高値
€0.94
安値
€0.94
時価総額
1296.49万
平均出来高
0.00
取引量
0.00
52 週高値
€4.34
52 週安値
€0.74
従業員数
21
始値
€0.94
高値
€0.94
安値
€0.94
時価総額
1296.49万
平均出来高
0.00
取引量
0.00
52 週高値
€4.34
52 週安値
€0.74
従業員数
21
ニュース記事
情報源: ウェブソース、ニュース パートナー
Investing.com
·
20 時間前
Lisata Therapeutics receives patent for certepetide cancer treatment
Investing.com UK
·
1 日前
Form PRE 14A Lisata Therapeutics For: 7 October By Investing.com
プロフィール
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Lisata Therapeutics, Inc. について